Paper41350407
Bioengineered photosynthetic nanothylakoids reshape the inflammatory microenvironment for rheumatoid arthritis therapy.
Li Z and 15 others. Nat Nanotechnol, 2026. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Bioengineered photosynthetic nanothylakoids reshape the inflammatory microenvironment for rheumatoid arthritis therapy. Papers, record 41350407. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41350407
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bioengineered photosynthetic nanothylakoids reshape the inflammatory microenvironment for rheumatoid arthritis therapy.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Inflammation | Major topic |
| Phototherapy | Major topic |
| Nanoparticles | Major topic |
| Animals | |
| Mice | |
| Macrophages | |
| Rats | |
| Polyethylene Glycols | |
| Photosynthesis | |
| Male | |
| Bioengineering | |
| Humans | |
| Cellular Microenvironment | |
| Folic Acid | |
| Thylakoids | |
| RAW 264.7 Cells | |
| Oxidative Stress |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37884660 | Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model. | Nat Nanotechnol | 2023 | https://conductscience.org/library/papers/37884660 | PubMed |
| 2 | 32601335 | Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. | Nat Med | 2020 | https://conductscience.org/library/papers/32601335 | PubMed |
| 3 | 30140291 | Bone Marrow-Derived Mesenchymal Stem Cells Exert Diverse Effects on Different Macrophage Subsets. | Stem Cells Int | 2018 | https://conductscience.org/library/papers/30140291 | PubMed |
| 4 | 33733490 | Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations. | Adv Mater | 2021 | https://conductscience.org/library/papers/33733490 | PubMed |
| 5 | 33476818 | Novel insights into macrophage diversity in rheumatoid arthritis synovium. | Autoimmun Rev | 2021 | https://conductscience.org/library/papers/33476818 | PubMed |
| 6 | 28612748 | Novel treatment strategies in rheumatoid arthritis. | Lancet | 2017 | https://conductscience.org/library/papers/28612748 | PubMed |
| 7 | 37083341 | Multifunctional Janus Nanoplatform for Efficiently Synergistic Theranostics of Rheumatoid Arthritis. | ACS Nano | 2023 | https://conductscience.org/library/papers/37083341 | PubMed |
| 8 | 38168040 | Surplus fatty acid synthesis increases oxidative stress in adipocytes and lnduces lipodystrophy. | Nat Commun | 2024 | https://conductscience.org/library/papers/38168040 | PubMed |
| 9 | 34078596 | Metabolically engineered stem cell-derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis. | Sci Adv | 2021 | https://conductscience.org/library/papers/34078596 | PubMed |
| 10 | 40123651 | Innate immunity-modulating nanobiomaterials for controlling inflammation resolution. | Matter | 2024 | https://conductscience.org/library/papers/40123651 | PubMed |
| 11 | 33526927 | Location, location, location: how the tissue microenvironment affects inflammation in RA. | Nat Rev Rheumatol | 2021 | https://conductscience.org/library/papers/33526927 | PubMed |
| 12 | 37880265 | Artificial photosynthetic cells with biotic-abiotic hybrid energy modules for customized CO2 conversion. | Nat Commun | 2023 | https://conductscience.org/library/papers/37880265 | PubMed |
| 13 | 37157020 | An ancestral molecular response to nanomaterial particulates. | Nat Nanotechnol | 2023 | https://conductscience.org/library/papers/37157020 | PubMed |
| 14 | 37500654 | Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37500654 | PubMed |
| 15 | 27959716 | Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27959716 | PubMed |
| 16 | 38040200 | Biosynthesis of phosphatidylglycerol in photosynthetic organisms. | Prog Lipid Res | 2024 | https://conductscience.org/library/papers/38040200 | PubMed |
| 17 | 38277492 | Microalgae-Based Hydrogel for Inflammatory Bowel Disease and Its Associated Anxiety and Depression. | Adv Mater | 2024 | https://conductscience.org/library/papers/38277492 | PubMed |
| 18 | 35787388 | The role of lipid components in lipid nanoparticles for vaccines and gene therapy. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/35787388 | PubMed |
| 19 | 30830763 | Synergistic Oxygen Generation and Reactive Oxygen Species Scavenging by Manganese Ferrite/Ceria Co-decorated Nanoparticles for Rheumatoid Arthritis Treatment. | ACS Nano | 2019 | https://conductscience.org/library/papers/30830763 | PubMed |
| 20 | 28360422 | Immunometabolism in early and late stages of rheumatoid arthritis. | Nat Rev Rheumatol | 2017 | https://conductscience.org/library/papers/28360422 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42949421 | JQ1 Inhibits the Hyperproliferation and Aggressiveness of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via Regulating IL7R. | Immun Inflamm Dis | 2026 | https://conductscience.org/library/papers/42949421 | PubMed |
| 42921895 | Spatiotemporally Precise Rheumatoid Arthritis Therapy via a Triple-Locked Cascaded Nanoplatform With Dual-Channel Self-Reporting. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42921895 | PubMed |
| 42819177 | Targeted Catalytic Anti-Inflammatory and Antioxidant Therapy for Aortic Dissection Using Biomimetic Nanomaterials. | ACS Omega | 2026 | https://conductscience.org/library/papers/42819177 | PubMed |
| 42814826 | A NIR-II AIEgen with superior fluorescence and photothermal performance for precision theranostics. | Sci Adv | 2026 | https://conductscience.org/library/papers/42814826 | PubMed |
| 42761614 | Stimuli-responsive structural transformation of adaptive peptide nanomaterials toward biomedical applications. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42761614 | PubMed |
| 42667089 | Organization from cell to tissue derived delivery systems for immunotherapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42667089 | PubMed |
| 42603980 | Dual-mode light/ROS-responsive microneedles enable adaptive nitric oxide therapy across tissue depths. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42603980 | PubMed |
| 42563363 | Stimuli-Responsive Nanoplatforms for Precision Intervention in Rheumatoid Arthritis. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2026 | https://conductscience.org/library/papers/42563363 | PubMed |
| 42421508 | Living Inorganic Nanomaterials: Design, Preparation, and Biomedical Applications. | Adv Mater | 2026 | https://conductscience.org/library/papers/42421508 | PubMed |
| 42403925 | Modulation of innate and adaptive immunity by pH-responsive nanozyme-like nanoparticles with high mobility for rheumatoid arthritis alleviation. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42403925 | PubMed |
| 42377939 | Bioinspired Artificial Bioenergetic Organelles: Design Principles, Nanofabrication and Therapeutic Translation. | Adv Mater | 2026 | https://conductscience.org/library/papers/42377939 | PubMed |
| 42310760 | Turmeric-derived nanovesicles reprogram pathological NETosis to mitigate inflammatory bone loss. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42310760 | PubMed |
| 42144642 | A self-powered chloroplast-driven nanophotosystem for treating skin photoaging through rejuvenating mitochondria and revitalizing senescent fibroblasts. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42144642 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41350407
GET https://conductscience.org/api/papers/v1/41350407/references?page=2